CDK2 inhibitors induce RB-independent tumor suppression in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer, with disease stabilization observed in patients.
- Open access
Moving in bioRxiv, Frontiers in Genetics, Nature Chemical Biology, Nature Communications, Blood, Cancer Research, Cell Reports, Nature Cancer.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
CDK2 inhibitors induce RB-independent tumor suppression in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer, with disease stabilization observed in patients.
Eighteen candidate TCDD-associated targets, including five hub genes, were identified in retinoblastoma, with CDK1 showing the strongest link to cell-cycle dysregulation.
Chronic exposure to cigarette and waterpipe smoke extracts causes telomere shortening and increases telomerase activity, promoting cancer progression in lung, colon, and breast cancer cells.
A novel CDC45 variant and a recurrent East Asian variant were identified in a Chinese MGORS7 patient, expanding the mutational spectrum of the disorder.
Deletion of cFLIP in B cells prevents diffuse large B-cell lymphoma development in mice, highlighting its essential role in lymphoma pathogenesis.
ARISC-RAP80 recognizes and cleaves K63-linked polyubiquitin chains through a unique three-subunit interface, enabling precise DNA damage response regulation.
Bi-allelic loss-of-function variants in CDK20 cause a severe ciliopathy with midline brain and facial anomalies in seven individuals from five families.
Chemically induced skin tumors mainly originate from Lgr6+ and Lrig1+ stem cells in the upper hair follicle, with fewer arising from other hair follicle populations.
Journals this month
Moving areas, week to 3 Oct 2026